Andrew Dillon, chief executive of the United Kingdom's National Institute for Health and Clinical Excellence, spoke to about three dozen journalists at an AHCJ event in London on Jan. 10.
Dillon discussed his young agency's role in advising the UK's National Health Service on the cost-effectiveness of medical treatments, and some of the subsequent rumbles across the Atlantic.
The event, hosted by Bloomberg News, was followed by a discussion about creating a U.K. chapter of AHCJ to hold more events like this one.
